North America Genomics Market

North America Genomics Market Size and Growth Rate:

According to the Research Report, the North America Genomics Market  Size was valued at USD 5.5 Billion in 2018 and was Expected to Reach USD 8.74 Billion by 2025 with a CAGR of 9.7% during the forecast period 2019-2025.

 North America Genomics Market Overview:

Genomics, the science of studying the interaction of genomes with various stimuli, has been the focus of extensive research and development activities over the years. This field provides a clear understanding of the genome and the use of research results to understand the role of the Genomics in the growth and survival of all living organisms and the importance of technologies that promise a better understanding of the interactions with the environment.

North America Genomics Market - Growth Drivers and Restraints:

The growth of the set of genomic data in research activities allowed doctors, biologists and patients to further investigate the genetic predisposition to certain diseases. It is anticipated that the clinical application of this data set plays an important role in the transformation of the healthcare system with the acquisition of more effective and reliable solutions for the management of diseases.

Clinical applications of genomic data are in an early phase, but health and research communities are trying to effectively integrate genetic information into clinical workflows. This, in turn, helps to overcome the gap between pathological research and clinical diagnosis and treatment. Increasing development of human genetic research in various public health programs such as consumer health programs and the screening of the population to optimize the preventative treatment of common chronic diseases will support the growth of the market in North America. To accelerate the investigation, it is expected that the market will expand with the growing investment of government agencies, finance agencies and biotechnology companies.

International financing organizations such as the NIH and the Welcome Trust participate in the financing of genetic research, which is expected to help research genomes around the North American region. One of the most important factors that is expected to affect this market is the amount and to what extent the medical community will use the available genomic information in personalized medicine. Scientists have shown that combining generated data from sequencing with diagnostics effectively improves the personalized treatment environment.

However, the lack of specialized specialists, the high cost of equipment and the lack of awareness of genomics, may limit the market in the future. The growing popularity of research institutes and companies and the growing preference for personalized pharmaceutical products will provide new opportunities for growth for players in the North American market.

North America Genomics Market – Regional Presence:

North America will lead in the future and represented more than 38% of the global Genomics market in 2018. The developed regions of North America are leading the market for Genomics due to abundant funds availability and the presence of a large number of companies. The continued funding of research on biosciences by private organizations and government agencies, further development of personalized medicines, greater investment by academic institutions in genome research, the presence of medical facilities, also facilitate the market demand. The latest generation and the early adoption of the technologies are driving the American market. Increased investment in research by government agencies, better patient awareness and the availability of sophisticated medical infrastructure have accelerated technological development in this market.

Some of the Promising Companies leading the North America Genomics Market Profiled in the Report are:

• Thermo Fisher Scientific
• Illumina
• QIAGEN NV
• Agilent Technologies
• Eurofins Scientific
• GE Healthcare
• BGI, Inc
• Oxford Nanopore Technologies
• Bio-Rad Laboratories
• F. Hoffmann-La Roche Ltd

The Research Report segments the North America Genomics Market into the following submarkets:

North America Genomics Market - By Product Type:

• Instruments/Systems
• Consumables
• Services

North America Genomics Market - By Applications:

• Epigenomics
• functional discovery
• biomarker

  • real-time PCR
  •  mass spectrometry
  • microarray analysis
  •  genomics
  •  statistical analysis
  • DNA sequencing

• path analysis

  • microarray analyzes
  • account-based analysis
  • real-time PCR
  •  proteomic tools

North America Genomics Market - By End-user:

• governmental and academic institutions
• clinical research
• biotech and pharmaceutical companies
• hospitals and clinics

North America Genomics Market – By Country:

• North America

  • United States                                
  • Canada